# INNOVATIVE TREATMENT OF SCARRED VOCAL FOLDS BY LOCAL INJECTION OF AUTOLOGOUS ADIPOSE-DERIVED STROMAL VASCULAR FRACTION: EFFICACY VERSUS PLACEBO

> **NCT05385159** · PHASE2 · UNKNOWN · sponsor: **Assistance Publique Hopitaux De Marseille** · enrollment: 36 (estimated)

## Conditions studied

- Scarred Vocal Folds

## Interventions

- **DRUG:** AUTOLOGOUS ADIPOSE-DERIVED STROMAL VASCULAR FRACTION
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05385159
- **Lead sponsor:** Assistance Publique Hopitaux De Marseille
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-09-22
- **Primary completion:** 2024-06
- **Final completion:** 2025-06
- **Target enrollment:** 36 (ESTIMATED)
- **Last updated:** 2023-09-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05385159

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05385159, "INNOVATIVE TREATMENT OF SCARRED VOCAL FOLDS BY LOCAL INJECTION OF AUTOLOGOUS ADIPOSE-DERIVED STROMAL VASCULAR FRACTION: EFFICACY VERSUS PLACEBO". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT05385159. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*